Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K40 in Scalp Seborrhoeic Dermatitis
NCT01137630Phase 3Completed
- Sponsor
- Moberg Pharma AB
- Start
- Feb 2007
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Kaprolac K40 in seborrheic dermatitis (SD), sponsored by Moberg Pharma AB. Started Feb 2007; status: completed.
02
Drugs
Kaprolac K40
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on NCT01137630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137630.